Design, synthesis, and discovery of novel non-peptide inhibitor of Caspase-3 using ligand based and structure based virtual screening approach-Reference-Cited by-同舟云学术

Design, synthesis, and discovery of novel non-peptide inhibitor of Caspase-3 using ligand based and structure based virtual screening approach

Published:2009-08 Issue:16 Volume:17 Page:6040-6047
ISSN:0968-0896
Container-title:Bioorganic & Medicinal Chemistry
language:en
Short-container-title:Bioorganic & Medicinal Chemistry

Author:

Jhansi Lakshmi P.,Suneel Kumar B.V.S.,Nayana Ravi Shasi,Srinivas Mohan M.,Bolligarla Ramababu,Das Samar K.,Uday Bhanu M.,Kondapi Anand K.,Ravikumar Muttineni

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference29 articles.

1. Programmed Cell Death in Animal Development

2. Emerging roles of caspase-3 in apoptosis

3. Selective inhibitors of apoptotic caspases: implications for novel therapeutic strategies

4. Apoptosis-based therapies

5. Systemic injection of a tripeptide inhibits the intracellular activation of CPP32-like proteases in vivo and fully protects mice against Fas-mediated fulminant liver destruction and death.

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the Potential of Plumbagin as an Activator of Caspase 3 for Non-small Cell Lung Carcinoma: A Comprehensive in silico Study;Indian Journal of Pharmaceutical Education and Research;2024-02-23

2. Virtual screening approach for the discovery of selective 5α-reductase type II inhibitors for benign prostatic hyperplasia treatment;Future Medicinal Chemistry;2023-12

3. Novel quinoxaline-based VEGFR-2 inhibitors to halt angiogenesis;Bioorganic Chemistry;2023-10

4. Novel quinoxaline-3-propanamides as VGFR-2 inhibitors and apoptosis inducers;RSC Advances;2023

5. Reinvestigation of Passerini and Ugi scaffolds as multistep apoptotic inducers via dual modulation of caspase 3/7 and P53-MDM2 signaling for halting breast cancer;RSC Advances;2023